N/A
Completed N=44
Feasibility of a Patient Directed Tool to Assess Heart Health Among Endometrial Cancer Survivors
Endometrial Cancer · Survivorship
Source: ClinicalTrials.gov NCT05796518 ↗
Enrolled (actual)
44
Serious AEs
0.0%
Results posted
Mar 2025
Primary outcomePrimary: Number of Participants to Complete Intervention - Feasibility — 42 Participants
Summary
Investigators are conducting this study to find out more about what heart health means to participants and how healthcare providers can best help to manage heart health. Participants will be asked to view an electronic tool designed to promote heart health awareness and help to manage heart health outside of the clinic. This study will provide important information to help investigators develop future programs that improve cancer patient's heart health after they complete their treatment.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Number of Participants to Complete Intervention - Feasibility |
42 | — |
| SECONDARY Number of Participants Stating Satisfaction With PREVENT Tool |
4; 36; 1; 1; 7; 32 | — |
| SECONDARY Number of Participants to Report Initiating Discussions Regarding Cardiovascular Health With Health Care Providers |
7; 28; 0; 4; 11; 28 | — |
Eligibility Criteria
Inclusion Criteria
- Scheduled for a routine surveillance visit for pathologically confirmed stages I-IV endometrial cancer
- Greater than or equal to 3 months post-potentially curative cancer treatment
- Patients must be at least 18 years of age
- Have a working email address
- Comfortable reading medical information in English, as per self-report
Exclusion Criteria
- Currently receiving treatment (e.g. radiation, chemotherapy, immunological treatments for endometrial cancer)
- Have a history of endometrial cancer recurrence
- Enrolled in hospice care or documentation of life expectancy < 6 months
Data sourced from ClinicalTrials.gov (NCT05796518). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.